Ventas (VTR) opened 2026 with Q1 revenue of about US$1.6b and basic EPS of US$0.12, while net income excluding extra items came in at US$55.9m. Over the last year, the company has seen trailing twelve month revenue move from about US$5.1b to US$6.1b and basic EPS rise from US$0.34 to US$0.56, with net income excluding extra items advancing from US$142.3m to US$260.4m. For investors tracking the story, that pairing of higher top line and thicker margins sets the stage for a closer look at what is driving the latest quarter.

See our full analysis for Ventas.

With the headline numbers on the table, the next step is to see how this earnings profile lines up with the prevailing narratives about Ventas, highlighting where the data supports the story and where it pushes back.

FFO Near US$440m Keeps Cash Flow Central

• Ventas reported Funds From Operations of US$439.6m in Q1 2026, up from US$378.8m in Q1 2025 and above each interim quarter in between, while trailing twelve month FFO reached US$1.68b compared with US$1.39b a year earlier.
• Consensus narrative points to margin expansion in senior housing and medical offices, and the FFO trend aligns with that view but also highlights financial pressure from interest costs.
  • Trailing twelve month net income excluding extra items was US$260.4m on US$6.11b of revenue. This equates to a 4.3% net margin, above the prior year's 2.8% and consistent with the idea of improving profitability from the property portfolio.
  • At the same time, analysis flags that earnings do not comfortably cover interest payments, so even with FFO and net income rising, the bullish focus on cash generation has to be weighed against this balance sheet risk.

Bulls who see senior housing FFO as the core earnings engine may want to test that view against the interest coverage flags highlighted in the detailed narrative 🐂 Ventas Bull Case

Revenue Near US$1.65b, Margins Track Higher

• Total revenue reached US$1.65b in Q1 2026 compared with US$1.35b in Q1 2025, and on a trailing twelve month basis the top line was US$6.11b with net income excluding extra items of US$260.4m, supporting the reported 4.3% net margin.
• Analysts' consensus view links senior housing occupancy gains and outpatient demand to stronger margins, and the numbers both support and qualify that story.
  • The move from a 2.8% to 4.3% net margin over the last year lines up with commentary about better operating leverage and rental escalators across senior housing and medical office properties.
  • However, quarterly net income excluding extra items was US$55.9m in Q1 2026 versus US$70.2m in Q4 2025, so while the trailing margin is higher than last year, readers should recognize that short term swings still show up inside that broader trend.

Share Price, DCF Fair Value And Interest Risk

• With a current share price of US$87.57 and a DCF fair value of US$113.63, the stock sits about 22.9% below that DCF estimate. The analyst price target of US$93.40 is closer to the market price and the trailing twelve month net margin sits at 4.3%.
• Bears focus on leverage, acquisition reliance and operator execution, and several data points give that cautious view real weight.
  • Interest payments are described as not well covered by earnings, which directly speaks to concerns about higher leverage and the ability to support both growth investments and an unstable dividend stream.
  • The P/S ratio of 7x is higher than the 5.5x industry average for North American Health Care REITs, so even with a DCF fair value above the share price, critics can still argue that the market is paying a premium multiple while key financial risks remain in place.

If you are weighing the downside case built around interest coverage and acquisition risk, the full bearish narrative helps put these Q1 figures in context 🐻 Ventas Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Ventas on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed signals or a clear story taking shape, either way, this is the moment to review the numbers yourself and decide how the balance of risks and rewards sits for you with the help of 3 key rewards and 3 important warning signs

See What Else Is Out There

Ventas carries a 4.3% net margin, limited interest coverage and a relatively high P/S ratio, so balance sheet risk and valuation pressure remain front of mind.

If those interest coverage concerns and premium pricing make you cautious, compare this profile with companies in the solid balance sheet and fundamentals stocks screener (44 results) to find sturdier, lower risk options fast.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.